Skip to main content
Erschienen in: World Journal of Surgery 12/2004

01.12.2004

Timing and Extent of Surgery in Patients with Familial Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia 2A-related RET Mutations Not Affecting Codon 634

verfasst von: Oliver Gimm, M.D., Jörg Ukkat, M.D., Barbara E. Niederle, M.D., Theresa Weber, M.D., Phuong Nguyen Thanh, M.D., Michael Brauckhoff, M.D., Bruno Niederle, M.D., Henning Dralle, M.D.

Erschienen in: World Journal of Surgery | Ausgabe 12/2004

Einloggen, um Zugang zu erhalten

Abstract

In hereditary medullary thyroid carcinoma (MTC), recommendations regarding timing and extent of surgery are mainly based on the data of patients with the codon 634 RET mutation, which is the most often affected codon. Little is known about whether these recommendations may also be applied to patients with less common RET mutations. We ascertained the data from 140 patients with FMTC/MEN2A-related RET mutation not affecting codon 634 who have been treated at three specialized centers. The several RET mutations found affected codons 611 (n = 17), 618 (n = 22), 620 (n = 17), 768 (n = 9), 790 (n = 24), 791 (n = 21), 804 (n = 23), and 891 (n = 7). For each codon, the age of the youngest patient with MTC only (41, 7, 18, 29, 13, 47, 20, and 15 years, respectively), MTC with lymph node metastases (46, 24, 21, 34, 46, 47, 50, and 76 years, respectively), and MTC with distant metastases (52, 69, 43, 68, 57, - , - , and 75 years, respectively) was determined. All patients with lymph node metastases had elevated basal calcitonin levels. Based on these data, a more individual recommendation regarding timing and extent of surgery can be given. Because neither gender nor the type of nucleotide substitution for a specific codon appeared to have a significant influence on the age of onset, this recommendation should be based on the affected codon, the age of the patient, and the calcitonin level. Recurrent laryngeal nerve palsy (n = 6) and hypoparathyroidism (n = 3) were rather rare and were found only in patients older than 30 and 43 years, respectively, giving evidence that surgery in young patients can be performed safely.
Literatur
1.
Zurück zum Zitat Marsh, D, Zori, R 2002Genetic insights into familial cancers–update and recent discoveriesCancer Lett.181125164PubMed Marsh, D, Zori, R 2002Genetic insights into familial cancers–update and recent discoveriesCancer Lett.181125164PubMed
2.
Zurück zum Zitat Ponder, BA, Ponder, MA, Coffey, R, et al. 1988Risk estimation and screening in families of patients with medullary thyroid carcinomaLancet1397401CrossRefPubMed Ponder, BA, Ponder, MA, Coffey, R,  et al. 1988Risk estimation and screening in families of patients with medullary thyroid carcinomaLancet1397401CrossRefPubMed
3.
Zurück zum Zitat Mulligan, LM, Kwok, JB, Healey, CS, et al. 1993Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature363458460CrossRefPubMed Mulligan, LM, Kwok, JB, Healey, CS,  et al. 1993Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature363458460CrossRefPubMed
4.
Zurück zum Zitat Donis-Keller, H, Dou, S, Chi, D, et al. 1993Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHum. Mol. Genet.2851856PubMed Donis-Keller, H, Dou, S, Chi, D,  et al. 1993Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHum. Mol. Genet.2851856PubMed
5.
Zurück zum Zitat Wells, SA,Jr, Chi, DD, Toshima, K, et al. 1994Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2AAnn. Surg.220237247PubMed Wells, SA,Jr, Chi, DD, Toshima, K,  et al. 1994Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2AAnn. Surg.220237247PubMed
6.
Zurück zum Zitat Dralle, H, Gimm, O, Simon, D, et al. 1998Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experienceWorld J. Surg.22744750CrossRefPubMed Dralle, H, Gimm, O, Simon, D,  et al. 1998Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experienceWorld J. Surg.22744750CrossRefPubMed
7.
Zurück zum Zitat Niccoli-Sire, P, Murat, A, Baudin, E, et al. 1999Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patientsEur. J. Endocrinol.141468474PubMed Niccoli-Sire, P, Murat, A, Baudin, E,  et al. 1999Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patientsEur. J. Endocrinol.141468474PubMed
8.
Zurück zum Zitat Eng, C, Clayton, D, Schuffenecker, I, et al. 1996The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisJ. A. M. A.27615751579PubMed Eng, C, Clayton, D, Schuffenecker, I,  et al. 1996The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisJ. A. M. A.27615751579PubMed
9.
Zurück zum Zitat Carlomagno, F, Salvatore, G, Cirafici, AM, et al. 1997The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotypeCancer Res.57391395PubMed Carlomagno, F, Salvatore, G, Cirafici, AM,  et al. 1997The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotypeCancer Res.57391395PubMed
10.
Zurück zum Zitat Iwashita, T, Kato, M, Murakami, H, et al. 1999Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinomaOncogene1839193922CrossRefPubMed Iwashita, T, Kato, M, Murakami, H,  et al. 1999Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinomaOncogene1839193922CrossRefPubMed
11.
Zurück zum Zitat Machens, A, Gimm, O, Hinze, R, et al. 2001Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical propertiesJ. Clin. Endocrinol. Metab.8611041109 Machens, A, Gimm, O, Hinze, R,  et al. 2001Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical propertiesJ. Clin. Endocrinol. Metab.8611041109
12.
Zurück zum Zitat Niccoli-Sire, P, Murat, A, Rohmer, V, et al. 2001Familial medullary thyroid carcinoma with noncysteine RET mutations: pheontype-genotype relationship in a large series of patientsJ. Clin. Endocrinol. Metab.8637463753 Niccoli-Sire, P, Murat, A, Rohmer, V,  et al. 2001Familial medullary thyroid carcinoma with noncysteine RET mutations: pheontype-genotype relationship in a large series of patientsJ. Clin. Endocrinol. Metab.8637463753
13.
Zurück zum Zitat Brandi, ML, Gagel, RF, Angeli, A, et al. 2001Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2J. Clin. Endocrinol. Metab.8656585671 Brandi, ML, Gagel, RF, Angeli, A,  et al. 2001Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2J. Clin. Endocrinol. Metab.8656585671
14.
Zurück zum Zitat Szinnai, G, Meier, C, Komminoth, P, et al. 2003Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysisPediatrics111E132E139CrossRefPubMed Szinnai, G, Meier, C, Komminoth, P,  et al. 2003Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysisPediatrics111E132E139CrossRefPubMed
15.
Zurück zum Zitat Yip, L, Cote, GJ, Shapiro, SE, et al. 2003Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipArch. Surg.138409416CrossRefPubMed Yip, L, Cote, GJ, Shapiro, SE,  et al. 2003Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationshipArch. Surg.138409416CrossRefPubMed
16.
Zurück zum Zitat Machens, A, Niccoli-Sire, P, Hoegel, J, et al. 2003Early malignant progression of hereditary medullary thyroid cancerN. Engl. J. Med.34915171525CrossRefPubMed Machens, A, Niccoli-Sire, P, Hoegel, J,  et al. 2003Early malignant progression of hereditary medullary thyroid cancerN. Engl. J. Med.34915171525CrossRefPubMed
17.
Zurück zum Zitat Lips, CJM, Landsvater, RM, Hoppener, JWM, et al. 1994Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2AN. Engl. J. Med.331828835CrossRefPubMed Lips, CJM, Landsvater, RM, Hoppener, JWM,  et al. 1994Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2AN. Engl. J. Med.331828835CrossRefPubMed
18.
Zurück zum Zitat Gonzalez-Yebra, B, Medrano, ME, Mantilla, A, et al. 2003Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutationEndocr. Pathol.147180CrossRefPubMed Gonzalez-Yebra, B, Medrano, ME, Mantilla, A,  et al. 2003Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutationEndocr. Pathol.147180CrossRefPubMed
19.
Zurück zum Zitat Punales, MK, Graf, H, Gross, JL, et al. 2003RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcomeJ. Clin. Endocrinol. Metab.8826442649CrossRefPubMed Punales, MK, Graf, H, Gross, JL,  et al. 2003RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcomeJ. Clin. Endocrinol. Metab.8826442649CrossRefPubMed
20.
Zurück zum Zitat Gimm, O, Niederle, BE, Weber, T, et al. 2002RET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome?Surgery132952959CrossRefPubMed Gimm, O, Niederle, BE, Weber, T,  et al. 2002RET proto-oncogene mutations affecting codon 790/791: a mild form of multiple endocrine neoplasia type 2A syndrome?Surgery132952959CrossRefPubMed
21.
Zurück zum Zitat Dralle, H, Damm, I, Scheumann, GF, et al. 1994Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinomaSurg. Today24112121PubMed Dralle, H, Damm, I, Scheumann, GF,  et al. 1994Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinomaSurg. Today24112121PubMed
22.
Zurück zum Zitat Feldman, GL, Edmonds, MW, Ainsworth, PJ, et al. 2000Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutationSurgery1289398CrossRefPubMed Feldman, GL, Edmonds, MW, Ainsworth, PJ,  et al. 2000Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG→ATG) mutationSurgery1289398CrossRefPubMed
23.
Zurück zum Zitat Lombardo, F, Baudin, E, Chiefari, E, et al. 2002Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804J. Clin. Endocrinol. Metab.8716741680 Lombardo, F, Baudin, E, Chiefari, E,  et al. 2002Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804J. Clin. Endocrinol. Metab.8716741680
24.
Zurück zum Zitat Fitze, G, Schierz, M, Bredow, J, et al. 2002Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutationsAnn. Surg.236570575CrossRefPubMed Fitze, G, Schierz, M, Bredow, J,  et al. 2002Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutationsAnn. Surg.236570575CrossRefPubMed
25.
Zurück zum Zitat Telander, RL, Zimmerman, D, Sizemore, GW, et al. 1989Medullary carcinoma in children. Results of early detection and surgeryArch. Surg.124841843PubMed Telander, RL, Zimmerman, D, Sizemore, GW,  et al. 1989Medullary carcinoma in children. Results of early detection and surgeryArch. Surg.124841843PubMed
26.
Zurück zum Zitat Skinner, MA, DeBenedetti, MK, Moley, JF, et al. 1996Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2BJ. Pediatr. Surg.31177181CrossRefPubMed Skinner, MA, DeBenedetti, MK, Moley, JF,  et al. 1996Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2BJ. Pediatr. Surg.31177181CrossRefPubMed
27.
Zurück zum Zitat Henry, JF, Gramatica, L, Denizot, A, et al. 1998Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinomaLangenbecks Arch. Surg.383167169PubMed Henry, JF, Gramatica, L, Denizot, A,  et al. 1998Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinomaLangenbecks Arch. Surg.383167169PubMed
28.
Zurück zum Zitat Cheah, WK, Arici, C, Ituarte, PH, et al. 2002Complications of neck dissection for thyroid cancerWorld J. Surg.2610131016CrossRefPubMed Cheah, WK, Arici, C, Ituarte, PH,  et al. 2002Complications of neck dissection for thyroid cancerWorld J. Surg.2610131016CrossRefPubMed
29.
Zurück zum Zitat Machens, A, Holzhausen, HJ, Thanh, PN, et al. 2003Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutationsSurgery134425431CrossRefPubMed Machens, A, Holzhausen, HJ, Thanh, PN,  et al. 2003Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutationsSurgery134425431CrossRefPubMed
30.
Zurück zum Zitat Berndt, I, Reuter, M, Saller, B, et al. 1998A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2AJ. Clin. Endocrinol. Metab.83770774 Berndt, I, Reuter, M, Saller, B,  et al. 1998A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2AJ. Clin. Endocrinol. Metab.83770774
31.
Zurück zum Zitat Frohnauer, MK, Decker, RA 2000Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?Surgery12810521057CrossRefPubMed Frohnauer, MK, Decker, RA 2000Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?Surgery12810521057CrossRefPubMed
32.
Zurück zum Zitat Shannon, KE, Gimm, O, Hinze, R, et al. 1999Germline V804M mutation in th RET proto-oncogene in two apparently sporadic cases of FMTC presenting in the seventh decade of lifeJ. Endocr. Genet.13945 Shannon, KE, Gimm, O, Hinze, R,  et al. 1999Germline V804M mutation in th RET proto-oncogene in two apparently sporadic cases of FMTC presenting in the seventh decade of lifeJ. Endocr. Genet.13945
33.
Zurück zum Zitat Zedenius, J, Larsson, C, Bergholm, U, et al. 1995Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomasJ. Clin. Endocrinol. Metab.8030883090CrossRefPubMed Zedenius, J, Larsson, C, Bergholm, U,  et al. 1995Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomasJ. Clin. Endocrinol. Metab.8030883090CrossRefPubMed
34.
Zurück zum Zitat Marsh, DJ, Learoyd, DL, Andrew, SD, et al. 1996Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomaClin. Endocrinol. (Oxf.)44249257CrossRef Marsh, DJ, Learoyd, DL, Andrew, SD,  et al. 1996Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomaClin. Endocrinol. (Oxf.)44249257CrossRef
35.
Zurück zum Zitat Schilling, T, Burck, J, Sinn, HP, et al. 2001Prognostic value of codon 918 (ATG→ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinomaInt. J. Cancer956266CrossRefPubMed Schilling, T, Burck, J, Sinn, HP,  et al. 2001Prognostic value of codon 918 (ATG→ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinomaInt. J. Cancer956266CrossRefPubMed
36.
Zurück zum Zitat Miyauchi, A, Futami, H, Hai, N, et al. 1999Two germline missense mutations at codons 804 and 806 of the RET proto- oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutationJpn. J. Cancer Res.9015 Miyauchi, A, Futami, H, Hai, N,  et al. 1999Two germline missense mutations at codons 804 and 806 of the RET proto- oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutationJpn. J. Cancer Res.9015
37.
Zurück zum Zitat Kasprzak, L, Nolet, S, Gaboury, L, et al. 2001Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RETJ. Med. Genet.38784787CrossRefPubMed Kasprzak, L, Nolet, S, Gaboury, L,  et al. 2001Familial medullary thyroid carcinoma and prominent corneal nerves associated with the germline V804M and V778I mutations on the same allele of RETJ. Med. Genet.38784787CrossRefPubMed
38.
Zurück zum Zitat Menko, FH, Luijt, RB, Valk, IA, et al. 2002Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918J. Clin. Endocrinol. Metab.87393397 Menko, FH, Luijt, RB, Valk, IA,  et al. 2002Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918J. Clin. Endocrinol. Metab.87393397
39.
Zurück zum Zitat Robledo, M, Gil, L, Pollan, M, et al. 2003Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2ACancer Res.6318141817PubMed Robledo, M, Gil, L, Pollan, M,  et al. 2003Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2ACancer Res.6318141817PubMed
40.
Zurück zum Zitat Niccoli-Sire, P, Murat, A, Rohmer, V, et al. 2003When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?Surgery13410291036CrossRefPubMed Niccoli-Sire, P, Murat, A, Rohmer, V,  et al. 2003When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?Surgery13410291036CrossRefPubMed
Metadaten
Titel
Timing and Extent of Surgery in Patients with Familial Medullary Thyroid Carcinoma/Multiple Endocrine Neoplasia 2A-related RET Mutations Not Affecting Codon 634
verfasst von
Oliver Gimm, M.D.
Jörg Ukkat, M.D.
Barbara E. Niederle, M.D.
Theresa Weber, M.D.
Phuong Nguyen Thanh, M.D.
Michael Brauckhoff, M.D.
Bruno Niederle, M.D.
Henning Dralle, M.D.
Publikationsdatum
01.12.2004
Erschienen in
World Journal of Surgery / Ausgabe 12/2004
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-004-7640-9

Weitere Artikel der Ausgabe 12/2004

World Journal of Surgery 12/2004 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.